Publications:

Clinical and genomic features of Chinese lung cancer patients with germline mutations.

Nature Communications

Peng, Wenying W; Li, Bin B; Li, Jin J; Chang, Lianpeng L; Bai, Jing J; Yi, Yuting Y; Chen, Rongrong R; Zhang, Yanyan Y; Chen, Chen C; Pu, Xingxiang X; Jiang, Meilin M; Li, Jia J; Zhong, Rui R; Xu, Fang F; Chen, Bolin B; Xu, Li L; Wang, Ning N; Huan, Jiaojiao J; Dai, Pingping P; Guan, Yanfang Y; Yang, Ling L; Xia, Xuefeng X; Yi, Xin X; Wang, Jiayin J; Yu, Fenglei F; Wu, Lin L

Publication Date: 2022-03-10

Variant appearance in text: ATM: 2120C>T; S707F

PubMed Link: 35273153

Variant Present in the following documents:

• 41467_2022_28840_MOESM7_ESM.xlsx, sheet 1

View BVdb publication page

Phase Ib dose-escalation study of the selective, non-covalent, reversible Bruton's tyrosine kinase inhibitor vecabrutinib in B-cell malignancies.

Haematologica

Allan, John N JN; Pinilla-Ibarz, Javier J; Gladstone, Douglas E DE; Patel, Krish K; Sharman, Jeff P JP; Wierda, William G WG; Choi, Michael Y MY; O'Brien, Susan M SM; Shadman, Mazyar M; Davids, Matthew S MS; Pagel, John M JM; Yimer, Habte A HA; Ward, Renee R; Acton, Gary G; Taverna, Pietro P; Combs, Daniel L DL; Fox, Judith A JA; Furman, Richard R RR; Brown, Jennifer R JR

Publication Date: 2022-04-01

Variant appearance in text: ATM: S707F

PubMed Link: 34937320

Variant Present in the following documents:

• 2021_280061_ALLAN_SUPPL.pdf

View BVdb publication page